IPO registrations (S-1, F-1) · Registrants
Nemaura Medical Inc.
- SEC CIK
- 1602078 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2014-03-28, last 2023-04-18; 2 initial registrations, 7 amendments
- Outcome
- Final prospectus filed 2023-05-15; declared effective 2014-08-12
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Business address
- 57 WEST 57TH STREET, Manhattan, NY 10019
- EIN
- 46-5027260
- EDGAR entity type
- operating
- Insiders and CEO pay
- Nemaura Medical Inc. on the corporate pages
Offering terms
- Final price
- $2.00 per share (424B4 filed 2023-05-15)
- Shares sold
- 4,796,206
- Gross proceeds
- $9,592,412 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol NMRD
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- SEC filer: Nemaura Medical Inc. EXACT (CIK (EXACT))
Filings 16
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2014-03-28 | S-1 | S-1 (registration) | Nemaura Medical Inc. | 0001173375-14-000085 ↗ |
| 2014-05-02 | S-1/A | S-1/A (amendment) | Nemaura Medical Inc. | 0001173375-14-000117 ↗ |
| 2014-06-16 | S-1/A | S-1/A (amendment) | Nemaura Medical Inc. | 0001173375-14-000148 ↗ |
| 2014-07-11 | S-1/A | S-1/A (amendment) | Nemaura Medical Inc. | 0001173375-14-000168 ↗ |
| 2014-07-30 | S-1/A | S-1/A (amendment) | Nemaura Medical Inc. | 0001173375-14-000186 ↗ |
| 2014-08-11 | S-1/A | S-1/A (amendment) | Nemaura Medical Inc. | 0001173375-14-000207 ↗ |
| 2014-08-12 | S-1/A | S-1/A (amendment) | Nemaura Medical Inc. | 0001173375-14-000219 ↗ |
| 2014-08-12 | EFFECT | EFFECT (declared effective) | Nemaura Medical Inc. | 9999999995-14-002468 ↗ |
| 2016-03-31 | EFFECT | EFFECT (declared effective) | Nemaura Medical Inc. | 9999999995-16-004096 ↗ |
| 2019-04-08 | EFFECT | EFFECT (declared effective) | Nemaura Medical Inc. | 9999999995-19-000641 ↗ |
| 2022-03-28 | EFFECT | EFFECT (declared effective) | Nemaura Medical Inc. | 9999999995-22-000738 ↗ |
| 2023-03-14 | S-1 | S-1 (registration) | Nemaura Medical Inc. | 0001079973-23-000328 ↗ |
| 2023-04-18 | S-1/A | S-1/A (amendment) | Nemaura Medical Inc. | 0001079973-23-000496 ↗ |
| 2023-05-12 | EFFECT | EFFECT (declared effective) | Nemaura Medical Inc. | 9999999995-23-001408 ↗ |
| 2023-05-15 | 424B4 | 424B4 (final prospectus) | Nemaura Medical Inc. | 0001079973-23-000707 ↗ |
| 2023-08-07 | EFFECT | EFFECT (declared effective) | Nemaura Medical Inc. | 9999999995-23-002294 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-18 | S-1/A | registration statement | $2.00 | 4,796,206 | $9,592,412 | Nasdaq NMRD | 0 | primary document; price line, shares headline, proceeds computed | document ↗ | |
| 2023-05-15 | 424B4 | final prospectus | $2.00 | 4,796,206 | $9,592,412 | Nasdaq NMRD | 0 | primary document; price line, shares headline, proceeds computed | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Chowdhury Dewan Fazlul Hoque | Director,Officer,TenPercentOwner | CEO and President; CEO & President; Chief Executive Officer | 4 | 2014–2022 | |
| Farrar Kathryn | Officer | Director of Finance | 1 | 2014 | |
| Ismail Sufyan | TenPercentOwner | 3 | 2014–2018 | ||
| Pomeroy Julie | Officer | Director of Finance | 1 | 2014 | |
| Timol Bashir | Director,Officer; Director,Officer,TenPercentOwner; Director,TenPercentOwner | Chief Business Officer | 4 | 2014–2022 | |
| Toon Richard | Officer | Technical & Bus. Dev. Manager | 1 | 2014 | |
| Anderson Iain | Officer | CFO | 1 | 2018 | |
| Natha Salim | Director | 2 | 2018–2022 | ||
| Johnson Timothy Christopher | Director | 2 | 2021–2022 | ||
| Mclarney Justin James | Officer | Chief Financial Officer | 2 | 2021–2022 | |
| Moore Thomas Peter | Director | 2 | 2021–2022 | ||
| Ghadar-Ghadr Arash | Officer | Chief Operating Officer | 2 | 2024 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | Nemaura Medical Inc. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, NY first:
- SWISSRAY INTERNATIONAL INC NY
- BIOPHAN TECHNOLOGIES INC NY
- ANGIODYNAMICS INC NY
- DarioHealth Corp. NY
- iNeedMD Holdings, Inc. NY
- PAVmed Inc. NY
- Beyond Air, Inc. NY
- OMNIA WELLNESS INC. NY
- INTELLIGENT BIO SOLUTIONS INC. NY
- Lucid Diagnostics Inc. NY
In other datasets, the same topic (Technology) in NY:
- Lobbying client: 1ST ROCHDALE COOPERATIVE GROUP LTD (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology